International safety notice
RA-71857 17Alpha-HydroxyProgesterone (17-OHP)-RIA-CT (2019-10-21)
CAN / Health Canada · CAN · Dec 13, 2019
Key facts
| Title | RA-71857 17Alpha-HydroxyProgesterone (17-OHP)-RIA-CT (2019-10-21) |
|---|---|
| Regulator | CAN / Health Canada |
| Country | CAN |
| Brand | 17Alpha-HydroxyProgesterone (17-OHP)-RIA-CT | |
| Manufacturer | DIASOURCE IMMUNOASSAYS S.A. 2 Bosquet St. Louvain de la neuve 1348 BELGIUM |
| Models | 193606, KIP1409 |
| Event type | Recall |
| Date | Dec 13, 2019 |
| Regulator page | recalls-rappels.canada.ca |
At a glance
- Yes Recall
- No Field safety notice
- 1–9 Matching device models in FDA data
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About International device safety notices
Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.
Source: National medical device regulators (as listed), compiled by Orca1